APA (7th ed.) Citation

T, L., N, H., A, H., J, J., SM, I., A, v. S., . . . RD, K. (2025). Predicted dolutegravir resistance in people living with HIV in South Africa during 2020-35: A modelling study. The Lancet. Global health, 13(4), e698. https://doi.org/10.1016/S2214-109X(24)00553-9

Chicago Style (17th ed.) Citation

T, Loosli, et al. "Predicted Dolutegravir Resistance in People Living with HIV in South Africa During 2020-35: A Modelling Study." The Lancet. Global Health 13, no. 4 (2025): e698. https://doi.org/10.1016/S2214-109X(24)00553-9.

MLA (9th ed.) Citation

T, Loosli, et al. "Predicted Dolutegravir Resistance in People Living with HIV in South Africa During 2020-35: A Modelling Study." The Lancet. Global Health, vol. 13, no. 4, 2025, p. e698, https://doi.org/10.1016/S2214-109X(24)00553-9.